Author: chc

Proposed OTC Drug Distribution Would Expand Patient Access to Rx Drugs

PDUFA V Bills Moving Forward Without Specific Marketing Provisions

CHC and TAC Comments Object to “Dual Modality” Risk Communication in DTC TV Ads

ACRE Study Finds Medical Journal Discussion of Academic/Industry Relationships Unbalanced

FDA Draft Guidance on DTC TV Ads Raises Important Questions

FTC to Industry: Adopt Consumer Privacy Best Practices Now

Call for Industry Comments: Proposed FDA Study on “Corrective” DTC TV Advertising

New Video Highlights Advances in CME Conflicts of Interest Policies

FDA Draft Guidance on DTC TV Ads Identifies Campaigns Subject to 45-day Pre-Review Process